NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Appropriations History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Appropriations | ₹6,351 Cr | ₹4,681 Cr | ₹3,382 Cr | ₹2,738 Cr | ₹2,680 Cr |
What is the latest Appropriations of NATCO PHARMA ?
Year | Appropriations |
---|---|
Mar2025 | ₹6,351 Cr |
Mar2024 | ₹4,681 Cr |
Mar2023 | ₹3,382 Cr |
Mar2022 | ₹2,738 Cr |
Mar2021 | ₹2,680 Cr |
How is Appropriations of NATCO PHARMA Trending?
Years | Appropriations | % Change | |
---|---|---|---|
Mar2025 | ₹6,351 Cr | 35.69 | |
Mar2024 | ₹4,681 Cr | 38.40 | |
Mar2023 | ₹3,382 Cr | 23.51 | |
Mar2022 | ₹2,738 Cr | 2.17 | |
Mar2021 | ₹2,680 Cr | - |
Compare Appropriations of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,443.8 Cr | 1.9% | -2.9% | -45.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,124.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 1.9% |
-2.9% |
-45.1% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses